| EMA number | EMEA/H/C/000822 |
| ATC code | J07BB02 |
| Authorisation | 14 May 2008 |
| Withdrawn | 17 December 2020 |
| Revision | 13 |
Active immunisation against H5N1 subtype of influenza-A virus. This indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared with H5N1 subtype strains. Prepandrix should be used in accordance with official guidance.